Agent Orange exposure significantly raises Parkinson's risk in veterans

Vietnam-era military veterans exposed to Agent Orange have a 57% greater risk of developing Parkinson's and related diseases compared with those who weren't exposed, according to new research that examined electronic health records covering millions of veterans.

The study, led by researchers with Oregon Health & Science University and the VA Portland Health Care System, published today in the journal JAMA Neurology.

Clinicians and veterans had long presumed a correlation between neurodegenerative conditions including Parkinson's and exposure to the chemical defoliant used by the American military during the Vietnam War, the researchers said.

The new study definitively draws the link, using a vast electronic database of health records across decades.

"Veterans have been talking about this for years and years," said co-author Lee Neilson, M.D., a neurologist formerly with OHSU and now with the University of Iowa. "I expect they will feel validated and heard with this study."

Neilson started the research project with colleagues in his previous capacity with OHSU.

Researchers examined electronic health records encompassing 4.9 million veterans who served during the Vietnam War era.

They homed in on conditions that would appear decades later, from 1999 to 2022, looking for an association between the level of exposure to Agent Orange and subsequent diagnoses of Parkinson's disease and the related disorder known as Lewy body dementia. They adjusted for confounding factors such as traumatic brain injury and frailty.

They found veterans with possible or presumed exposure to Agent Orange were 44% more likely to develop Parkinson's and 66% more likely to develop Lewy body dementia compared with those who weren't exposed to the herbicide. Veterans with higher exposure through direct handling and spraying were 99% more likely to develop Parkinson's.

Overall, the study found exposure associated with a 57% greater risk of the two related neurodegenerative conditions.

This is the first study in veterans to identify that increased risk of Parkinson's is associated with heavier exposure to Agent Orange. We're catching up with history in a way."

Gregory Scott, M.D., Ph.D., co-senior author, associate professor of pathology, OHSU School of Medicine and pathologist at the VA Portland

The study found heightened risks among veterans who directly sprayed or handled Agent Orange as members of the Army Chemical Corps and Operation Air Force Ranch Hand.

OHSU President Shereef Elnahal, M.D., M.B.A., who previously served as undersecretary of health in the U.S. Department of Veterans Affairs, noted that the PACT Act of 2022 rightly extended healthcare benefits to military veterans exposed to toxic substances like Agent Orange, removing the burden of proof for veterans trying to access care. This new research reinforces why that was so important. 

 "This research offers critical insight for veterans who may have been diagnosed with Parkinson's even decades after their exposure to Agent Orange in Southeast Asia," Elnahal said. "Veterans who put themselves in harm's way deserve to know the truth no matter how long it takes."

The study may validate the experience of veterans, but Scott said it should also raise awareness about the long-term health risks of prolonged exposure to other chemical pesticides and herbicides.

"I think this adds weight to the idea that we ought to get on top of this and not wait 50 years for the next herbicide to be linked to neurodegenerative disease," Scott said.

In addition to Neilson and Scott, co-authors included Miranda Lim, M.D., Ph.D., and Jonathan Elliott, Ph.D., of OHSU and the VA Portland Health Care System. Lim also is affiliated with the Oregon Institute of Occupational Health Sciences at OHSU.

Source:
Journal reference:

Scott, G. D., et al. (2026). Agent Orange Exposure and Diagnosis of Parkinson Disease and Related Disorders Among US Veterans. JAMA Neurology. DOI: 10.1001/jamaneurol.2026.4219. https://jamanetwork.com/journals/jamaneurology/fullarticle/2856723

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Memory problems may matter more than slower thinking for dementia risk in frail adults